These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17569121)

  • 21. Which patients with hepatitis C develop liver complications?
    Khan MH; Farrell GC; Byth K; Lin R; Weltman M; George J; Samarasinghe D; Kench J; Kaba S; Crewe E; Liddle C
    Hepatology; 2000 Feb; 31(2):513-20. PubMed ID: 10655279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
    Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
    J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
    J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
    Zeremski M; Dimova RB; Pillardy J; de Jong YP; Jacobson IM; Talal AH
    J Infect Dis; 2016 Oct; 214(8):1164-70. PubMed ID: 27485356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
    Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
    World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
    Abad-Fernández M; Moreno A; Dronda F; del Campo S; Quereda C; Casado JL; Pérez-Elías MJ; Moreno S; Vallejo A
    AIDS; 2015 Feb; 29(4):401-9. PubMed ID: 25565497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of HCV infection on hepatic fibrosis in patients of thalassaemia major.
    Anwar M; Nadeem A; Jamal S; Dilawar M; Ali W; Aziz S; Ayyub M; Ahmed P; Ashraf T; Khan B; Hussain T; Hussain S;
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):200-3. PubMed ID: 16542600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks of a range of alcohol intake on hepatitis C-related fibrosis.
    Monto A; Patel K; Bostrom A; Pianko S; Pockros P; McHutchison JG; Wright TL
    Hepatology; 2004 Mar; 39(3):826-34. PubMed ID: 14999703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection.
    Williams MJ; Lang-Lenton M;
    J Viral Hepat; 2011 Jan; 18(1):17-22. PubMed ID: 20088889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major.
    El-Shabrawi MH; Zein El Abedin MY; Omar N; Kamal NM; Elmakarem SA; Khattab S; El-Sayed HM; El-Hennawy A; Ali AS
    Arab J Gastroenterol; 2012 Jun; 13(2):45-8. PubMed ID: 22980590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis C: a clinical-histopathological study].
    Pálsson PS; Jónasson JG; Olafsson S
    Laeknabladid; 2008 Jan; 94(1):13-7. PubMed ID: 18204107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.
    García-Samaniego J; Soriano V; Castilla J; Bravo R; Moreno A; Carbó J; Iñiguez A; González J; Muñoz F
    Am J Gastroenterol; 1997 Jul; 92(7):1130-4. PubMed ID: 9219784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history and response to treatment of HCV infection among Egyptian survivors of childhood malignancy.
    El-Raziky MS; Halawa EF; Draz IH; Ali MS
    Pediatr Hematol Oncol; 2015 Mar; 32(2):138-45. PubMed ID: 25264733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
    Merchante N; Macías J; Ramayo E; Vergara S; García-García JA; Mira JA; Corzo JE; Gómez-Mateos JM; Lozano F; Pineda JA
    J Viral Hepat; 2006 Jul; 13(7):449-56. PubMed ID: 16792538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.